HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jia Fan Selected Research

Residual Neoplasm

1/2022Integration of Inflammation-Immune Factors to Build Prognostic Model Predictive of Prognosis and Minimal Residual Disease for Hepatocellular Carcinoma.
4/2011Risk factors for residual tumor after resection of hepatocellular carcinoma.
3/2010[Effect of postoperative adjuvant transarterial chemoembolization upon early recurrence after radical resection of hepatocellular carcinoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jia Fan Research Topics

Disease

381Neoplasms (Cancer)
05/2024 - 01/2000
358Hepatocellular Carcinoma (Hepatoma)
03/2024 - 06/2002
114Neoplasm Metastasis (Metastasis)
01/2024 - 01/2000
40Liver Neoplasms (Liver Cancer)
12/2023 - 01/2000
39Cholangiocarcinoma
01/2024 - 03/2006
23Fibrosis (Cirrhosis)
09/2022 - 09/2003
21Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 05/2005
19Infections
01/2023 - 06/2005
19Lymphatic Metastasis
01/2021 - 01/2004
18Liver Diseases (Liver Disease)
02/2023 - 07/2005
17Carcinogenesis
01/2023 - 01/2013
16Thrombosis (Thrombus)
01/2022 - 11/2003
15Inflammation (Inflammations)
10/2023 - 04/2007
8Disease Progression
05/2024 - 09/2014
8Colorectal Neoplasms (Colorectal Cancer)
11/2022 - 01/2007
8Liver Failure
06/2022 - 01/2019
8Hypoxia (Hypoxemia)
09/2020 - 06/2006
7COVID-19
01/2024 - 01/2021
7Hepatitis
01/2017 - 09/2003
6Nasopharyngeal Carcinoma
07/2023 - 06/2015
6Circulating Neoplastic Cells
11/2021 - 09/2014
6Chronic Hepatitis B
12/2019 - 12/2011
5Hypertension (High Blood Pressure)
02/2024 - 07/2016
5Breast Neoplasms (Breast Cancer)
01/2022 - 05/2012
5Carcinoma (Carcinomatosis)
01/2020 - 09/2004
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2024 - 11/2022
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2023 - 01/2022
4Wounds and Injuries (Trauma)
01/2023 - 01/2014
4Obesity
11/2022 - 10/2017
4Margins of Excision
01/2022 - 03/2006
4End Stage Liver Disease
06/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

82Biomarkers (Surrogate Marker)IBA
03/2024 - 03/2005
67Proteins (Proteins, Gene)FDA Link
05/2024 - 04/2004
35MicroRNAs (MicroRNA)IBA
12/2022 - 10/2009
31alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022 - 06/2002
29Messenger RNA (mRNA)IBA
10/2023 - 01/2000
20Sorafenib (BAY 43-9006)FDA Link
01/2024 - 08/2008
19RNA (Ribonucleic Acid)IBA
12/2023 - 10/2009
19Fetal Proteins (Fetoprotein)IBA
05/2023 - 04/2011
18lenvatinibIBA
02/2024 - 03/2021
17Indicators and Reagents (Reagents)IBA
11/2022 - 12/2013
16Small Interfering RNA (siRNA)IBA
01/2022 - 10/2007
14Immune Checkpoint InhibitorsIBA
05/2024 - 01/2019
14DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2010
12CateninsIBA
02/2024 - 09/2013
12LigandsIBA
01/2023 - 04/2007
12EnzymesIBA
11/2022 - 09/2004
11Circular RNAIBA
02/2024 - 01/2016
11AntigensIBA
02/2024 - 05/2005
11Glucose (Dextrose)FDA LinkGeneric
01/2023 - 11/2010
11gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
07/2020 - 09/2003
10InterferonsIBA
01/2022 - 10/2009
10Peptides (Polypeptides)IBA
01/2021 - 10/2009
9BilirubinIBA
06/2022 - 01/2017
9AlbuminsIBA
06/2022 - 12/2008
9Capsules (Microcapsules)IBA
01/2021 - 01/2002
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 06/2006
8Transcription Factors (Transcription Factor)IBA
01/2022 - 12/2010
8Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2021 - 08/2009
8Tumor Biomarkers (Tumor Markers)IBA
01/2019 - 06/2009
7CytokinesIBA
01/2024 - 07/2012
7Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2024 - 11/2009
7AntibodiesIBA
11/2023 - 03/2021
7Cell-Free Nucleic AcidsIBA
07/2022 - 01/2011
7Long Noncoding RNAIBA
12/2021 - 02/2016
7Thymidine PhosphorylaseIBA
10/2009 - 12/2003
6Tyrosine Kinase InhibitorsIBA
03/2024 - 01/2020
6LipidsIBA
01/2020 - 11/2010
6TransferasesIBA
01/2019 - 01/2009
6Interferon-alpha (Interferon Alfa)IBA
01/2013 - 09/2004
5Alanine Transaminase (SGPT)IBA
02/2024 - 11/2007
5Therapeutic UsesIBA
01/2023 - 04/2007
5Competitive Endogenous RNAIBA
11/2022 - 01/2017
5IntegrinsIBA
10/2022 - 11/2008
5Phosphotransferases (Kinase)IBA
01/2022 - 12/2015
5ChemokinesIBA
01/2022 - 06/2009
5Oncogene Proteins (Oncogene Protein)IBA
01/2022 - 12/2016
5OsteopontinIBA
12/2019 - 04/2004
5CarbohydratesIBA
08/2019 - 08/2009
5Keratin-19 (Keratin 19)IBA
06/2018 - 06/2008
5Sirolimus (Rapamycin)FDA Link
01/2012 - 05/2006
4ChromatinIBA
05/2024 - 10/2016
4ProteomeIBA
02/2024 - 03/2005
45-hydroxymethylcytosineIBA
01/2023 - 04/2014
4B7-H1 AntigenIBA
10/2022 - 12/2020
4Complement System Proteins (Complement)IBA
08/2022 - 08/2012
4Antiviral Agents (Antivirals)IBA
01/2022 - 07/2016
4UbiquitinIBA
10/2021 - 11/2012

Therapy/Procedure

110Therapeutics
02/2024 - 11/2003
51Hepatectomy
12/2023 - 03/2006
41Liver Transplantation
11/2023 - 04/2005
29Radiotherapy
02/2024 - 12/2002
27Immunotherapy
05/2024 - 07/2009
26Drug Therapy (Chemotherapy)
12/2023 - 02/2000
8Transplantation
01/2023 - 05/2006
6Aftercare (After-Treatment)
04/2024 - 03/2006
6Ligation
08/2022 - 05/2004
5Radiofrequency Ablation
04/2019 - 11/2008
5Palliative Care (Palliative Therapy)
11/2014 - 02/2005
4Precision Medicine
01/2023 - 05/2012